logo
[breadcrumb_custom]

Tag: (CTXR)

Stock

Citius Pharmaceuticals Inc (CTXR) Stock: Navigating a Year of Volatility

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Citius Pharmaceuticals Inc’s current trading price is -52.27% away from its 52-week high, while its distance from the 52-week low is 36.03%. The stock’s price range for this period has been between $0.60 and $1.71 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.69 million for the day, a number notably lower than the average daily volume of 0.75 million over the last three months. Citius Pharmaceuticals Inc ‘s stock market performance

THMO
Finance

Citius Pharmaceuticals Inc: Weathering Stock Market Storms with 141.64M Market Cap

Citius Pharmaceuticals Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $1.71 on 04/17/23 and a low of $0.60 for the same time frame on 02/08/24. 52-week price history of CTXR Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Citius Pharmaceuticals Inc’s current trading price is -47.94% away from its 52-week high, while its distance from the 52-week low is 48.38%. The stock’s price range during the 52-week period has remained between $0.60 and $1.71. In

Industry

CTXR: Riding the Market Waves of Growth and Decline in 2023

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 36.15%.However, over the last six months, we can see a weaker performance of 48.87%. Over the last 30 days, the price of CTXR has fallen by 34.06%. And in the last five days, it has surged by 30.68%. Citius Pharmaceuticals Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $1.71 on 04/17/23 and the lowest value

TOST Stock
Finance

CTXR’s Stock Market Adventure: -0.82% YTD Growth Amidst Volatility

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant loss of -0.82% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 7.85%. Over the past 30 days, the price of CTXR has leaped by -2.55%. And in the last five days, it has surged by 8.93%. Citius Pharmaceuticals Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached